<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03527745</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT03527745</nct_id>
  </id_info>
  <brief_title>Albendazole Dose Finding and Pharmacokinetics in Children and Adults</brief_title>
  <official_title>Efficacy and Safety of Ascending Dosages of Albendazole Against T. Trichiura and Hookworm in Preschool- and School-aged Children and Adults: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jennifer Keiser</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Suisse de Recherches Scientifiques en Cote d'Ivoire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Tropical &amp; Public Health Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a single-blind randomized clinical trial conducted in rural Côte d'Ivoire. This&#xD;
      study aims at providing evidence on the dose-response of increasing oral albendazole dosages&#xD;
      against whipworm (T. trichiura) and hookworm infections in preschoolers (2-5 years),&#xD;
      school-aged children (6-12 years) and adults (≥ 21 years).&#xD;
&#xD;
      The primary objective is to determine cure rates (primary end point, i.e. conversion from&#xD;
      being egg positive pre-treatment to egg negative post-treatment). Secondary objectives&#xD;
      involve the determination of egg reduction rates (the reduction in the number of excreted&#xD;
      eggs from baseline (prior to treatment) to follow-up) and the assessment of safety of&#xD;
      ascending dosages of albendazole (secondary end points). In addition, key pharmacokinetic&#xD;
      parameters will be determined from blood samples collected with a micro-sampling device&#xD;
      (secondary end point).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a single-blind randomized clinical trial conducted in Côte d'Ivoire. This study&#xD;
      aims at providing evidence on the efficacy and safety of ascending oral albendazole dosages&#xD;
      in children and adults infected with T. trichiura and hookworm. In preschool-aged children&#xD;
      (2-5 years) (i) 200 mg, (ii) 400 mg and (iii) 600 mg; in schoolchildren (6-12 years) and&#xD;
      adults (≥ 21 years) (i) 200 mg (only for hookworm infections), (ii) 400 mg, (iii) 600 mg and&#xD;
      (iv) 800 mg will be administered and efficacy, safety and pharmacokinetic parameters will be&#xD;
      assessed.&#xD;
&#xD;
      The primary objective is to determine the dose-response based on cure rates of albendazole in&#xD;
      preschool-aged children (2-5 years), school-aged children (6-12 years) and adults (≥ 21&#xD;
      years) infected with T. trichiura and hookworm.&#xD;
&#xD;
      The secondary objectives of the trial are to determine the efficacy based on egg reduction&#xD;
      rates of albendazole in preschool-aged children, school-aged children and adults, to&#xD;
      determine an exposure (including length of time that the drug concentration is above the MIC,&#xD;
      Cmax, AUC)-response correlation of albendazole in preschool-aged children, school-aged&#xD;
      children and adults, to evaluate the safety and tolerability of albendazole in preschool-aged&#xD;
      children, school-aged children and adults, and to determine the efficacy against concomitant&#xD;
      soil-transmitted helminthiasis (Ascaris lumbricoides).&#xD;
&#xD;
      After obtaining informed consent from individual/parents and/or caregiver, the medical&#xD;
      history of the participants will be assessed with a standardized questionnaire, in addition&#xD;
      to a clinical examination and venipuncture to examine biochemical parameters in the blood&#xD;
      carried out by the study physician before treatment. Enrollment will be based on two stool&#xD;
      samples that will be collected, if possible, on two consecutive days or otherwise within a&#xD;
      maximum of 5 days.&#xD;
&#xD;
      All stool samples will be examined with duplicated Kato-Katz thick smears by experienced&#xD;
      laboratory technicians. Randomization of participants into the treatment arms will be&#xD;
      stratified according to intensity of infection. All participants will be interviewed before&#xD;
      treatment, 3 and 24 hours and 3 weeks after treatment about the occurrence of adverse events.&#xD;
      Children and adults will be sampled using finger pricking for micro-blood sampling at 0, 1,&#xD;
      2, 3, 4, 6, 8, 24 hours post-dosing.&#xD;
&#xD;
      The primary analysis will include all participants with primary end point data (available&#xD;
      case analysis). Supplementary, a per-protocol analysis and an intention-to-treat analysis&#xD;
      will be conducted. CRs will be calculated as the percentage of egg-positive subjects at&#xD;
      baseline who become egg-negative after treatment. Differences among CRs will be analysed by&#xD;
      using crude logistic regressions and adjusted logistic regressions (adjustment for age, sex,&#xD;
      and height).&#xD;
&#xD;
      Geometric and arithmetic mean egg counts will be calculated for the different treatment arms&#xD;
      before and after treatment to assess the corresponding ERRs. Bootstrap resampling method with&#xD;
      2,000 replicates will be used to calculate 95% confidence intervals (CIs) for differences in&#xD;
      ERRs. Noncompartmental and nonlinear mixed-effects (NLME) modeling will be used to determine&#xD;
      PK parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 23, 2018</start_date>
  <completion_date type="Actual">April 17, 2019</completion_date>
  <primary_completion_date type="Actual">April 17, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cure Rate Against T. Trichiura and Hookworm Infections</measure>
    <time_frame>14-21 days after treatment</time_frame>
    <description>The conversion from being egg positive pre-treatment to egg negative post-treatment, or cure rate (CR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Egg-reduction Rate (ERR) Against T. Trichiura and Hookworm Infections, Respectively</measure>
    <time_frame>14-21 days after treatment</time_frame>
    <description>Percent change in geometric mean eggs per gram of stool from before to after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Concentration (Cmax) of Albendazole and Its Metabolites</measure>
    <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
    <description>To determine maximum drug concentration (Cmax) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Reach Cmax (Tmax) of Albendazole and Its Metabolites</measure>
    <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
    <description>To determine time to reach Cmax (tmax) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Curve (AUC) of Albendazole and Its Metabolites</measure>
    <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
    <description>To determine the area under the curve (AUC) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">700</enrollment>
  <condition>Trichuriasis</condition>
  <condition>Hookworm Infections</condition>
  <arm_group>
    <arm_group_label>200 mg albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>against T. trichiura in preschool-aged children or against hookworm infections in preschool-aged children, school-aged children and adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>400 mg albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>against T. trichiura in preschool-aged children, school-aged children and adults or against hookworm infections in preschool-aged children, school-aged children and adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>600 mg albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>against T. trichiura in preschool-aged children, school-aged children and adults or hookworm infections in preschool-aged children, school-aged children and adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>800 mg albendazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>against T. trichiura in school-aged children and adults or against hookworm infections in school-aged children and adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>against T. trichiura in preschool-aged children, school-aged children and adults or hookworm infections in preschool-aged children, school-aged children and adults</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>Single dose of albendazole (200mg, dependent on treatment cohort)</description>
    <arm_group_label>200 mg albendazole</arm_group_label>
    <other_name>Zentel®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>Single dose of albendazole (400mg, dependent on treatment cohort)</description>
    <arm_group_label>400 mg albendazole</arm_group_label>
    <other_name>Zentel®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>Single dose of albendazole (600mg, dependent on treatment cohort)</description>
    <arm_group_label>600 mg albendazole</arm_group_label>
    <other_name>Zentel®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albendazole</intervention_name>
    <description>Single dose of albendazole (800mg, dependent on treatment cohort)</description>
    <arm_group_label>800 mg albendazole</arm_group_label>
    <other_name>Zentel®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo tablets will be obtained from Fagron, Germany.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male and female adults (≥21 years), preschool-aged children (2-5 years) and&#xD;
             school-aged children (6-12 years) infected with T. trichiura/hookworm&#xD;
&#xD;
          2. Written informed consent/assent signed from parent/guardian&#xD;
&#xD;
          3. Positive for T. trichiura/hookworm by at least two slides of the quadruple Kato-Katz&#xD;
             thick smears and infection intensities of at least 100 eggs per gram of stool (EPG)&#xD;
&#xD;
          4. Agree to comply with study procedures, including provision of two stool samples at the&#xD;
             beginning (baseline) and approximately three weeks after treatment (follow-up).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of acute or uncontrolled systemic illnesses (e.g. severe anemia, infection,&#xD;
             clinical malaria) as assessed by a medical doctor, upon initial clinical assessment&#xD;
             and liver function tests.&#xD;
&#xD;
          2. Known or reported history of chronic illness such as HIV, acute or chronic hepatitis,&#xD;
             cancer, diabetes, chronic heart disease or renal disease.&#xD;
&#xD;
          3. Prior treatment with anthelmintics (eg, diethylcarbamazine [DEC], suramin, ivermectin,&#xD;
             mebendazole or albendazole) within 4 weeks before planned test article administration.&#xD;
&#xD;
          4. Received any investigational drugs or investigational devices within 4 weeks before&#xD;
             administration of test article that may confound safety and/or efficacy assessments.&#xD;
&#xD;
          5. Known or suspected allergy to benzimidazoles.&#xD;
&#xD;
          6. Pregnant (urine testing) or breastfeeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)</name>
      <address>
        <city>Abidjan</city>
        <country>Côte D'Ivoire</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Côte D'Ivoire</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>May 3, 2018</study_first_submitted>
  <study_first_submitted_qc>May 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <results_first_submitted>August 11, 2020</results_first_submitted>
  <results_first_submitted_qc>December 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 6, 2021</results_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Tropical &amp; Public Health Institute</investigator_affiliation>
    <investigator_full_name>Jennifer Keiser</investigator_full_name>
    <investigator_title>Prof. Jennifer Keiser, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hookworm Infections</mesh_term>
    <mesh_term>Ancylostomiasis</mesh_term>
    <mesh_term>Trichuriasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albendazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/45/NCT03527745/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo Against T. Trichiura in PSAC</title>
          <description>Placebo against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="P2">
          <title>ALB 200 mg Against T. Trichiura in PSAC</title>
          <description>200 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="P3">
          <title>ALB 400 mg Against T. Trichiura in PSAC</title>
          <description>400 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="P4">
          <title>ALB 600 mg Against T. Trichiura in PSAC</title>
          <description>600 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="P5">
          <title>Placebo Against T. Trichiura in SAC</title>
          <description>Placebo against T. trichiura in school-aged children</description>
        </group>
        <group group_id="P6">
          <title>ALB 400 mg Against T. Trichiura in SAC</title>
          <description>400 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="P7">
          <title>ALB 600 mg Against T. Trichiura in SAC</title>
          <description>600 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="P8">
          <title>ALB 800 mg Against T. Trichiura in SAC</title>
          <description>800 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="P9">
          <title>Placebo Against T. Trichiura in Adults</title>
          <description>Placebo against T. trichiura in adults</description>
        </group>
        <group group_id="P10">
          <title>ALB 400 mg Against T. Trichiura in Adults</title>
          <description>400 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="P11">
          <title>ALB 600 mg Against T. Trichiura in Adults</title>
          <description>600 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="P12">
          <title>ALB 800 mg Against T. Trichiura in Adults</title>
          <description>800 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="P13">
          <title>Placebo Against Hookworm in PSAC</title>
          <description>Placebo against hookworm in preschool-aged children</description>
        </group>
        <group group_id="P14">
          <title>ALB 200 mg Against Hookworm in PSAC</title>
          <description>200 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="P15">
          <title>ALB 400 mg Against Hookworm in PSAC</title>
          <description>400 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="P16">
          <title>ALB 600 mg Against Hookworm in PSAC</title>
          <description>600 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="P17">
          <title>Placebo Against Hookworm in SAC</title>
          <description>Placebo against hookworm in school-aged children</description>
        </group>
        <group group_id="P18">
          <title>ALB 200 mg Against Hookworm in SAC</title>
          <description>200 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="P19">
          <title>ALB 400 mg Against Hookworm in SAC</title>
          <description>400 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="P20">
          <title>ALB 600 mg Against Hookworm in SAC</title>
          <description>600 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="P21">
          <title>ALB 800 mg Against Hookworm in SAC</title>
          <description>800 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="P22">
          <title>Placebo Against Hookworm in Adults</title>
          <description>Placebo against hookworm in adults</description>
        </group>
        <group group_id="P23">
          <title>ALB 200 mg Against Hookworm in Adults</title>
          <description>200 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="P24">
          <title>ALB 400 mg Against Hookworm in Adults</title>
          <description>400 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="P25">
          <title>ALB 600 mg Against Hookworm in Adults</title>
          <description>600 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="P26">
          <title>ALB 800 mg Against Hookworm in Adults</title>
          <description>800 mg of albendazole against hookworm in adults</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="27"/>
                <participants group_id="P5" count="46"/>
                <participants group_id="P6" count="45"/>
                <participants group_id="P7" count="46"/>
                <participants group_id="P8" count="43"/>
                <participants group_id="P9" count="10"/>
                <participants group_id="P10" count="11"/>
                <participants group_id="P11" count="9"/>
                <participants group_id="P12" count="12"/>
                <participants group_id="P13" count="0">During screening, the principal investigator decided to remove the this arm due to recruitment.</participants>
                <participants group_id="P14" count="13"/>
                <participants group_id="P15" count="13"/>
                <participants group_id="P16" count="12"/>
                <participants group_id="P17" count="24"/>
                <participants group_id="P18" count="27"/>
                <participants group_id="P19" count="27"/>
                <participants group_id="P20" count="29"/>
                <participants group_id="P21" count="26"/>
                <participants group_id="P22" count="40"/>
                <participants group_id="P23" count="41"/>
                <participants group_id="P24" count="38"/>
                <participants group_id="P25" count="40"/>
                <participants group_id="P26" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="18"/>
                <participants group_id="P5" count="46"/>
                <participants group_id="P6" count="43"/>
                <participants group_id="P7" count="43"/>
                <participants group_id="P8" count="41"/>
                <participants group_id="P9" count="7"/>
                <participants group_id="P10" count="9"/>
                <participants group_id="P11" count="8"/>
                <participants group_id="P12" count="11"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="13"/>
                <participants group_id="P15" count="13"/>
                <participants group_id="P16" count="12"/>
                <participants group_id="P17" count="23"/>
                <participants group_id="P18" count="27"/>
                <participants group_id="P19" count="27"/>
                <participants group_id="P20" count="28"/>
                <participants group_id="P21" count="25"/>
                <participants group_id="P22" count="35"/>
                <participants group_id="P23" count="35"/>
                <participants group_id="P24" count="30"/>
                <participants group_id="P25" count="39"/>
                <participants group_id="P26" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="6"/>
                <participants group_id="P24" count="8"/>
                <participants group_id="P25" count="1"/>
                <participants group_id="P26" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="5"/>
                <participants group_id="P23" count="6"/>
                <participants group_id="P24" count="8"/>
                <participants group_id="P25" count="1"/>
                <participants group_id="P26" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The Placebo against hookworm in PSAC arm was removed from the trial after discussion with with principal investigators.</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo Against T. Trichiura in PSAC</title>
          <description>Placebo against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="B2">
          <title>ALB 200 mg Against T. Trichiura in PSAC</title>
          <description>200 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="B3">
          <title>ALB 400 mg Against T. Trichiura in PSAC</title>
          <description>400 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="B4">
          <title>ALB 600 mg Against T. Trichiura in PSAC</title>
          <description>600 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="B5">
          <title>Placebo Against T. Trichiura in SAC</title>
          <description>Placebo against T. trichiura in school-aged children</description>
        </group>
        <group group_id="B6">
          <title>ALB 400 mg Against T. Trichiura in SAC</title>
          <description>400 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="B7">
          <title>ALB 600 mg Against T. Trichiura in SAC</title>
          <description>600 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="B8">
          <title>ALB 800 mg Against T. Trichiura in SAC</title>
          <description>800 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="B9">
          <title>Placebo Against T. Trichiura in Adults</title>
          <description>Placebo against T. trichiura in adults (&gt;21 years)</description>
        </group>
        <group group_id="B10">
          <title>ALB 400 mg Against T. Trichiura in Adults</title>
          <description>400 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="B11">
          <title>ALB 600 mg Against T. Trichiura in Adults</title>
          <description>600 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="B12">
          <title>ALB 800 mg Against T. Trichiura in Adults</title>
          <description>800 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="B13">
          <title>Placebo Against Hookworm in PSAC</title>
          <description>Placebo against hookworm in preschool-aged children</description>
        </group>
        <group group_id="B14">
          <title>ALB 200 mg Against Hookworm in PSAC</title>
          <description>200 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="B15">
          <title>ALB 400 mg Against Hookworm in PSAC</title>
          <description>400 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="B16">
          <title>ALB 600 mg Against Hookworm in PSAC</title>
          <description>600 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="B17">
          <title>Placebo Against Hookworm in SAC</title>
          <description>Placebo against hookworm in school-aged children</description>
        </group>
        <group group_id="B18">
          <title>ALB 200 mg Against Hookworm in SAC</title>
          <description>200 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="B19">
          <title>ALB 400 mg Against Hookworm in SAC</title>
          <description>400 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="B20">
          <title>ALB 600 mg Against Hookworm in SAC</title>
          <description>600 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="B21">
          <title>ALB 800 mg Against Hookworm in SAC</title>
          <description>800 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="B22">
          <title>Placebo Against Hookworm in Adults</title>
          <description>Placebo against hookworm in adults (&gt;21 years)</description>
        </group>
        <group group_id="B23">
          <title>ALB 200 mg Against Hookworm in Adults</title>
          <description>200 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="B24">
          <title>ALB 400 mg Against Hookworm in Adults</title>
          <description>400 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="B25">
          <title>ALB 600 mg Against Hookworm in Adults</title>
          <description>600 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="B26">
          <title>ALB 800 mg Against Hookworm in Adults</title>
          <description>800 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="B27">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="27"/>
            <count group_id="B5" value="46"/>
            <count group_id="B6" value="45"/>
            <count group_id="B7" value="46"/>
            <count group_id="B8" value="43"/>
            <count group_id="B9" value="10"/>
            <count group_id="B10" value="11"/>
            <count group_id="B11" value="9"/>
            <count group_id="B12" value="12"/>
            <count group_id="B13" value="0"/>
            <count group_id="B14" value="13"/>
            <count group_id="B15" value="13"/>
            <count group_id="B16" value="12"/>
            <count group_id="B17" value="24"/>
            <count group_id="B18" value="27"/>
            <count group_id="B19" value="27"/>
            <count group_id="B20" value="29"/>
            <count group_id="B21" value="26"/>
            <count group_id="B22" value="40"/>
            <count group_id="B23" value="41"/>
            <count group_id="B24" value="38"/>
            <count group_id="B25" value="40"/>
            <count group_id="B26" value="37"/>
            <count group_id="B27" value="700"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.1" spread="0.9"/>
                    <measurement group_id="B2" value="4.0" spread="0.9"/>
                    <measurement group_id="B3" value="3.8" spread="1.1"/>
                    <measurement group_id="B4" value="4.0" spread="0.9"/>
                    <measurement group_id="B5" value="8.9" spread="1.9"/>
                    <measurement group_id="B6" value="8.9" spread="1.9"/>
                    <measurement group_id="B7" value="8.7" spread="2.0"/>
                    <measurement group_id="B8" value="8.8" spread="1.8"/>
                    <measurement group_id="B9" value="44.3" spread="12.3"/>
                    <measurement group_id="B10" value="40.5" spread="11.9"/>
                    <measurement group_id="B11" value="36.6" spread="12.2"/>
                    <measurement group_id="B12" value="44.8" spread="15.9"/>
                    <measurement group_id="B14" value="3.8" spread="1.2"/>
                    <measurement group_id="B15" value="3.8" spread="1.3"/>
                    <measurement group_id="B16" value="3.8" spread="1.1"/>
                    <measurement group_id="B17" value="9.1" spread="2.2"/>
                    <measurement group_id="B18" value="9.1" spread="1.9"/>
                    <measurement group_id="B19" value="9.8" spread="1.9"/>
                    <measurement group_id="B20" value="9.2" spread="2.2"/>
                    <measurement group_id="B21" value="9.4" spread="2.3"/>
                    <measurement group_id="B22" value="35.4" spread="10.3"/>
                    <measurement group_id="B23" value="39.8" spread="12.2"/>
                    <measurement group_id="B24" value="36.3" spread="12.2"/>
                    <measurement group_id="B25" value="39.2" spread="11.5"/>
                    <measurement group_id="B26" value="35.7" spread="12.0"/>
                    <measurement group_id="B27" value="17.7" spread="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="25"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="19"/>
                    <measurement group_id="B8" value="17"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="9"/>
                    <measurement group_id="B11" value="7"/>
                    <measurement group_id="B12" value="8"/>
                    <measurement group_id="B14" value="5"/>
                    <measurement group_id="B15" value="9"/>
                    <measurement group_id="B16" value="8"/>
                    <measurement group_id="B17" value="8"/>
                    <measurement group_id="B18" value="12"/>
                    <measurement group_id="B19" value="8"/>
                    <measurement group_id="B20" value="5"/>
                    <measurement group_id="B21" value="7"/>
                    <measurement group_id="B22" value="7"/>
                    <measurement group_id="B23" value="16"/>
                    <measurement group_id="B24" value="7"/>
                    <measurement group_id="B25" value="7"/>
                    <measurement group_id="B26" value="9"/>
                    <measurement group_id="B27" value="282"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="21"/>
                    <measurement group_id="B6" value="30"/>
                    <measurement group_id="B7" value="27"/>
                    <measurement group_id="B8" value="26"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="4"/>
                    <measurement group_id="B14" value="8"/>
                    <measurement group_id="B15" value="4"/>
                    <measurement group_id="B16" value="4"/>
                    <measurement group_id="B17" value="16"/>
                    <measurement group_id="B18" value="15"/>
                    <measurement group_id="B19" value="19"/>
                    <measurement group_id="B20" value="24"/>
                    <measurement group_id="B21" value="19"/>
                    <measurement group_id="B22" value="33"/>
                    <measurement group_id="B23" value="25"/>
                    <measurement group_id="B24" value="31"/>
                    <measurement group_id="B25" value="33"/>
                    <measurement group_id="B26" value="28"/>
                    <measurement group_id="B27" value="418"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                    <count group_id="B7" value="0"/>
                    <count group_id="B8" value="0"/>
                    <count group_id="B9" value="0"/>
                    <count group_id="B10" value="0"/>
                    <count group_id="B11" value="0"/>
                    <count group_id="B12" value="0"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="0"/>
                    <count group_id="B15" value="0"/>
                    <count group_id="B16" value="0"/>
                    <count group_id="B17" value="0"/>
                    <count group_id="B18" value="0"/>
                    <count group_id="B19" value="0"/>
                    <count group_id="B20" value="0"/>
                    <count group_id="B21" value="0"/>
                    <count group_id="B22" value="0"/>
                    <count group_id="B23" value="0"/>
                    <count group_id="B24" value="0"/>
                    <count group_id="B25" value="0"/>
                    <count group_id="B26" value="0"/>
                    <count group_id="B27" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B27" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>T. trichuris median eggs per gram</title>
          <units>eggs per gram of stool</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="216" lower_limit="120" upper_limit="438"/>
                    <measurement group_id="B2" value="264" lower_limit="96" upper_limit="558"/>
                    <measurement group_id="B3" value="210" lower_limit="144" upper_limit="510"/>
                    <measurement group_id="B4" value="228" lower_limit="150" upper_limit="726"/>
                    <measurement group_id="B5" value="387" lower_limit="222" upper_limit="1068"/>
                    <measurement group_id="B6" value="426" lower_limit="192" upper_limit="1266"/>
                    <measurement group_id="B7" value="507" lower_limit="186" upper_limit="1134"/>
                    <measurement group_id="B8" value="414" lower_limit="162" upper_limit="1116"/>
                    <measurement group_id="B9" value="138" lower_limit="114" upper_limit="270"/>
                    <measurement group_id="B10" value="168" lower_limit="114" upper_limit="504"/>
                    <measurement group_id="B11" value="156" lower_limit="114" upper_limit="288"/>
                    <measurement group_id="B12" value="195" lower_limit="150" upper_limit="402"/>
                    <measurement group_id="B14" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B15" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B16" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B17" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B18" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B19" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B20" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B21" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B22" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B23" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B24" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B25" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B26" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B27" value="294" lower_limit="162" upper_limit="972"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>T. trichuris infection intensity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Light (1-999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="32"/>
                    <measurement group_id="B6" value="30"/>
                    <measurement group_id="B7" value="31"/>
                    <measurement group_id="B8" value="30"/>
                    <measurement group_id="B9" value="10"/>
                    <measurement group_id="B10" value="10"/>
                    <measurement group_id="B11" value="9"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="1"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (1000-9999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="14"/>
                    <measurement group_id="B6" value="15"/>
                    <measurement group_id="B7" value="15"/>
                    <measurement group_id="B8" value="12"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Heavy (&gt;= 10000 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not infected</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="13"/>
                    <measurement group_id="B15" value="13"/>
                    <measurement group_id="B16" value="11"/>
                    <measurement group_id="B17" value="22"/>
                    <measurement group_id="B18" value="25"/>
                    <measurement group_id="B19" value="27"/>
                    <measurement group_id="B20" value="29"/>
                    <measurement group_id="B21" value="24"/>
                    <measurement group_id="B22" value="39"/>
                    <measurement group_id="B23" value="41"/>
                    <measurement group_id="B24" value="38"/>
                    <measurement group_id="B25" value="40"/>
                    <measurement group_id="B26" value="36"/>
                    <measurement group_id="B27" value="358"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>hookworm median eggs per gram</title>
          <units>eggs per gram of stool</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B3" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B4" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B5" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B6" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B7" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B8" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B9" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B10" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B11" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B12" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="B14" value="216" lower_limit="150" upper_limit="618"/>
                    <measurement group_id="B15" value="126" lower_limit="60" upper_limit="540"/>
                    <measurement group_id="B16" value="252" lower_limit="111" upper_limit="423"/>
                    <measurement group_id="B17" value="183" lower_limit="78" upper_limit="450"/>
                    <measurement group_id="B18" value="126" lower_limit="72" upper_limit="336"/>
                    <measurement group_id="B19" value="138" lower_limit="78" upper_limit="246"/>
                    <measurement group_id="B20" value="156" lower_limit="84" upper_limit="528"/>
                    <measurement group_id="B21" value="153" lower_limit="66" upper_limit="366"/>
                    <measurement group_id="B22" value="157" lower_limit="96" upper_limit="318"/>
                    <measurement group_id="B23" value="126" lower_limit="54" upper_limit="444"/>
                    <measurement group_id="B24" value="96" lower_limit="54" upper_limit="264"/>
                    <measurement group_id="B25" value="189" lower_limit="63" upper_limit="570"/>
                    <measurement group_id="B26" value="114" lower_limit="84" upper_limit="216"/>
                    <measurement group_id="B27" value="132" lower_limit="66" upper_limit="369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>hookworm infection intensity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Light (1-1999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="12"/>
                    <measurement group_id="B16" value="11"/>
                    <measurement group_id="B17" value="22"/>
                    <measurement group_id="B18" value="26"/>
                    <measurement group_id="B19" value="27"/>
                    <measurement group_id="B20" value="27"/>
                    <measurement group_id="B21" value="24"/>
                    <measurement group_id="B22" value="38"/>
                    <measurement group_id="B23" value="40"/>
                    <measurement group_id="B24" value="38"/>
                    <measurement group_id="B25" value="40"/>
                    <measurement group_id="B26" value="36"/>
                    <measurement group_id="B27" value="363"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (2000-3999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="2"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="2"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="1"/>
                    <measurement group_id="B27" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Heavy (&gt;= 4000 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not infected</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="45"/>
                    <measurement group_id="B6" value="44"/>
                    <measurement group_id="B7" value="44"/>
                    <measurement group_id="B8" value="40"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="10"/>
                    <measurement group_id="B11" value="9"/>
                    <measurement group_id="B12" value="12"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>A. lumbricoides infection intensity</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="27"/>
                    <count group_id="B5" value="46"/>
                    <count group_id="B6" value="45"/>
                    <count group_id="B7" value="46"/>
                    <count group_id="B8" value="43"/>
                    <count group_id="B9" value="10"/>
                    <count group_id="B10" value="11"/>
                    <count group_id="B11" value="9"/>
                    <count group_id="B12" value="12"/>
                    <count group_id="B13" value="0"/>
                    <count group_id="B14" value="13"/>
                    <count group_id="B15" value="13"/>
                    <count group_id="B16" value="12"/>
                    <count group_id="B17" value="24"/>
                    <count group_id="B18" value="27"/>
                    <count group_id="B19" value="27"/>
                    <count group_id="B20" value="29"/>
                    <count group_id="B21" value="26"/>
                    <count group_id="B22" value="40"/>
                    <count group_id="B23" value="41"/>
                    <count group_id="B24" value="38"/>
                    <count group_id="B25" value="40"/>
                    <count group_id="B26" value="37"/>
                    <count group_id="B27" value="700"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Light (1-4999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="8"/>
                    <measurement group_id="B7" value="4"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (5000-49999 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="6"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Heavy (&gt;= 50000 epg)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="0"/>
                    <measurement group_id="B27" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not infected</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="24"/>
                    <measurement group_id="B5" value="33"/>
                    <measurement group_id="B6" value="27"/>
                    <measurement group_id="B7" value="36"/>
                    <measurement group_id="B8" value="30"/>
                    <measurement group_id="B9" value="10"/>
                    <measurement group_id="B10" value="8"/>
                    <measurement group_id="B11" value="9"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="13"/>
                    <measurement group_id="B16" value="11"/>
                    <measurement group_id="B17" value="23"/>
                    <measurement group_id="B18" value="26"/>
                    <measurement group_id="B19" value="27"/>
                    <measurement group_id="B20" value="28"/>
                    <measurement group_id="B21" value="26"/>
                    <measurement group_id="B22" value="40"/>
                    <measurement group_id="B23" value="41"/>
                    <measurement group_id="B24" value="38"/>
                    <measurement group_id="B25" value="39"/>
                    <measurement group_id="B26" value="37"/>
                    <measurement group_id="B27" value="614"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cure Rate Against T. Trichiura and Hookworm Infections</title>
        <description>The conversion from being egg positive pre-treatment to egg negative post-treatment, or cure rate (CR).</description>
        <time_frame>14-21 days after treatment</time_frame>
        <population>An analysis set of all randomized participants who provided any follow-up data was used to perform an available-case analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Against T. Trichiura in PSAC</title>
            <description>Placebo against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O2">
            <title>ALB 200 mg Against T. Trichiura in PSAC</title>
            <description>200 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O3">
            <title>ALB 400 mg Against T. Trichiura in PSAC</title>
            <description>400 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O4">
            <title>ALB 600 mg Against T. Trichiura in PSAC</title>
            <description>600 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O5">
            <title>Placebo Against T. Trichiura in SAC</title>
            <description>Placebo against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O6">
            <title>ALB 400 mg Against T. Trichiura in SAC</title>
            <description>400 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O7">
            <title>ALB 600 mg Against T. Trichiura in SAC</title>
            <description>600 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O8">
            <title>ALB 800 mg Against T. Trichiura in SAC</title>
            <description>800 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O9">
            <title>Placebo Against T. Trichiura in Adults</title>
            <description>Placebo against T. trichiura in adults</description>
          </group>
          <group group_id="O10">
            <title>ALB 400 mg Against T. Trichiura in Adults</title>
            <description>400 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O11">
            <title>ALB 600 mg Against T. Trichiura in Adults</title>
            <description>600 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O12">
            <title>ALB 800 mg Against T. Trichiura in Adults</title>
            <description>800 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O13">
            <title>Placebo Against Hookworm in PSAC</title>
            <description>Placebo against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O14">
            <title>ALB 200 mg Against Hookworm in PSAC</title>
            <description>200 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O15">
            <title>ALB 400 mg Against Hookworm in PSAC</title>
            <description>400 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O16">
            <title>ALB 600 mg Against Hookworm in PSAC</title>
            <description>600 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O17">
            <title>Placebo Against Hookworm in SAC</title>
            <description>Placebo against hookworm in school-aged children</description>
          </group>
          <group group_id="O18">
            <title>ALB 200 mg Against Hookworm in SAC</title>
            <description>200 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O19">
            <title>ALB 400 mg Against Hookworm in SAC</title>
            <description>400 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O20">
            <title>ALB 600 mg Against Hookworm in SAC</title>
            <description>600 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O21">
            <title>ALB 800 mg Against Hookworm in SAC</title>
            <description>800 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O22">
            <title>Placebo Against Hookworm in Adults</title>
            <description>Placebo against hookworm in adults</description>
          </group>
          <group group_id="O23">
            <title>ALB 200 mg Against Hookworm in Adults</title>
            <description>200 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O24">
            <title>ALB 400 mg Against Hookworm in Adults</title>
            <description>400 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O25">
            <title>ALB 600 mg Against Hookworm in Adults</title>
            <description>600 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O26">
            <title>ALB 800 mg Against Hookworm in Adults</title>
            <description>800 mg of albendazole against hookworm in adults</description>
          </group>
        </group_list>
        <measure>
          <title>Cure Rate Against T. Trichiura and Hookworm Infections</title>
          <description>The conversion from being egg positive pre-treatment to egg negative post-treatment, or cure rate (CR).</description>
          <population>An analysis set of all randomized participants who provided any follow-up data was used to perform an available-case analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="18"/>
                <count group_id="O5" value="46"/>
                <count group_id="O6" value="43"/>
                <count group_id="O7" value="43"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="7"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="8"/>
                <count group_id="O12" value="11"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="13"/>
                <count group_id="O15" value="13"/>
                <count group_id="O16" value="12"/>
                <count group_id="O17" value="23"/>
                <count group_id="O18" value="27"/>
                <count group_id="O19" value="27"/>
                <count group_id="O20" value="28"/>
                <count group_id="O21" value="25"/>
                <count group_id="O22" value="35"/>
                <count group_id="O23" value="35"/>
                <count group_id="O24" value="30"/>
                <count group_id="O25" value="39"/>
                <count group_id="O26" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Cured</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="7"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="5"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O14" value="9"/>
                    <measurement group_id="O15" value="8"/>
                    <measurement group_id="O16" value="10"/>
                    <measurement group_id="O17" value="10"/>
                    <measurement group_id="O18" value="17"/>
                    <measurement group_id="O19" value="20"/>
                    <measurement group_id="O20" value="18"/>
                    <measurement group_id="O21" value="19"/>
                    <measurement group_id="O22" value="5"/>
                    <measurement group_id="O23" value="16"/>
                    <measurement group_id="O24" value="16"/>
                    <measurement group_id="O25" value="22"/>
                    <measurement group_id="O26" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not cured</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="13"/>
                    <measurement group_id="O5" value="43"/>
                    <measurement group_id="O6" value="36"/>
                    <measurement group_id="O7" value="32"/>
                    <measurement group_id="O8" value="34"/>
                    <measurement group_id="O9" value="6"/>
                    <measurement group_id="O10" value="4"/>
                    <measurement group_id="O11" value="4"/>
                    <measurement group_id="O12" value="8"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="5"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="13"/>
                    <measurement group_id="O18" value="10"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="10"/>
                    <measurement group_id="O21" value="6"/>
                    <measurement group_id="O22" value="30"/>
                    <measurement group_id="O23" value="19"/>
                    <measurement group_id="O24" value="14"/>
                    <measurement group_id="O25" value="17"/>
                    <measurement group_id="O26" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Egg-reduction Rate (ERR) Against T. Trichiura and Hookworm Infections, Respectively</title>
        <description>Percent change in geometric mean eggs per gram of stool from before to after treatment</description>
        <time_frame>14-21 days after treatment</time_frame>
        <population>An analysis set of all randomized participants who provided any follow-up data was used to perform an available-case analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Against T. Trichiura in PSAC</title>
            <description>Placebo against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O2">
            <title>ALB 200 mg Against T. Trichiura in PSAC</title>
            <description>200 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O3">
            <title>ALB 400 mg Against T. Trichiura in PSAC</title>
            <description>400 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O4">
            <title>ALB 600 mg Against T. Trichiura in PSAC</title>
            <description>600 mg of albendazole against T. trichiura in preschool-aged children</description>
          </group>
          <group group_id="O5">
            <title>Placebo Against T. Trichiura in SAC</title>
            <description>Placebo against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O6">
            <title>ALB 400 mg Against T. Trichiura in SAC</title>
            <description>400 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O7">
            <title>ALB 600 mg Against T. Trichiura in SAC</title>
            <description>600 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O8">
            <title>ALB 800 mg Against T. Trichiura in SAC</title>
            <description>800 mg of albendazole against T. trichiura in school-aged children</description>
          </group>
          <group group_id="O9">
            <title>Placebo Against T. Trichiura in Adults</title>
            <description>Placebo against T. trichiura in adults (&gt;21 years)</description>
          </group>
          <group group_id="O10">
            <title>ALB 400 mg Against T. Trichiura in Adults</title>
            <description>400 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O11">
            <title>ALB 600 mg Against T. Trichiura in Adults</title>
            <description>600 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O12">
            <title>ALB 800 mg Against T. Trichiura in Adults</title>
            <description>800 mg of albendazole against T. trichiura in adults</description>
          </group>
          <group group_id="O13">
            <title>Placebo Against Hookworm in PSAC</title>
            <description>Placebo against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O14">
            <title>ALB 200 mg Against Hookworm in PSAC</title>
            <description>200 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O15">
            <title>ALB 400 mg Against Hookworm in PSAC</title>
            <description>400 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O16">
            <title>ALB 600 mg Against Hookworm in PSAC</title>
            <description>600 mg of albendazole against hookworm in preschool-aged children</description>
          </group>
          <group group_id="O17">
            <title>Placebo Against Hookworm in SAC</title>
            <description>Placebo against hookworm in school-aged children</description>
          </group>
          <group group_id="O18">
            <title>ALB 200 mg Against Hookworm in SAC</title>
            <description>200 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O19">
            <title>ALB 400 mg Against Hookworm in SAC</title>
            <description>400 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O20">
            <title>ALB 600 mg Against Hookworm in SAC</title>
            <description>600 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O21">
            <title>ALB 800 mg Against Hookworm in SAC</title>
            <description>800 mg of albendazole against hookworm in school-aged children</description>
          </group>
          <group group_id="O22">
            <title>Placebo Against Hookworm in Adults</title>
            <description>Placebo against hookworm in adults (&gt;21 years)</description>
          </group>
          <group group_id="O23">
            <title>ALB 200 mg Against Hookworm in Adults</title>
            <description>200 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O24">
            <title>ALB 400 mg Against Hookworm in Adults</title>
            <description>400 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O25">
            <title>ALB 600 mg Against Hookworm in Adults</title>
            <description>600 mg of albendazole against hookworm in adults</description>
          </group>
          <group group_id="O26">
            <title>ALB 800 mg Against Hookworm in Adults</title>
            <description>800 mg of albendazole against hookworm in adults</description>
          </group>
        </group_list>
        <measure>
          <title>Egg-reduction Rate (ERR) Against T. Trichiura and Hookworm Infections, Respectively</title>
          <description>Percent change in geometric mean eggs per gram of stool from before to after treatment</description>
          <population>An analysis set of all randomized participants who provided any follow-up data was used to perform an available-case analysis.</population>
          <units>percent change</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="18"/>
                <count group_id="O5" value="46"/>
                <count group_id="O6" value="43"/>
                <count group_id="O7" value="43"/>
                <count group_id="O8" value="41"/>
                <count group_id="O9" value="7"/>
                <count group_id="O10" value="9"/>
                <count group_id="O11" value="8"/>
                <count group_id="O12" value="11"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="13"/>
                <count group_id="O15" value="13"/>
                <count group_id="O16" value="12"/>
                <count group_id="O17" value="23"/>
                <count group_id="O18" value="27"/>
                <count group_id="O19" value="27"/>
                <count group_id="O20" value="28"/>
                <count group_id="O21" value="25"/>
                <count group_id="O22" value="35"/>
                <count group_id="O23" value="35"/>
                <count group_id="O24" value="30"/>
                <count group_id="O25" value="39"/>
                <count group_id="O26" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.1" lower_limit="53.5" upper_limit="91.2"/>
                    <measurement group_id="O2" value="63.8" lower_limit="33.1" upper_limit="83.1"/>
                    <measurement group_id="O3" value="87.1" lower_limit="67.3" upper_limit="95.3"/>
                    <measurement group_id="O4" value="88.5" lower_limit="70.4" upper_limit="95.7"/>
                    <measurement group_id="O5" value="55.9" lower_limit="26.1" upper_limit="75.2"/>
                    <measurement group_id="O6" value="82.0" lower_limit="67.8" upper_limit="90.5"/>
                    <measurement group_id="O7" value="88.4" lower_limit="74.8" upper_limit="94.8"/>
                    <measurement group_id="O8" value="78.7" lower_limit="60.5" upper_limit="89.1"/>
                    <measurement group_id="O9" value="85.2" lower_limit="65.9" upper_limit="95.3"/>
                    <measurement group_id="O10" value="97.7" lower_limit="86.7" upper_limit="99.8"/>
                    <measurement group_id="O11" value="94.7" lower_limit="61.0" upper_limit="99.6"/>
                    <measurement group_id="O12" value="92.6" lower_limit="71.9" upper_limit="98.5"/>
                    <measurement group_id="O14" value="99.0" lower_limit="94.7" upper_limit="99.9"/>
                    <measurement group_id="O15" value="96.2" lower_limit="83.5" upper_limit="99.4"/>
                    <measurement group_id="O16" value="99.6" lower_limit="98.5" upper_limit="100.0"/>
                    <measurement group_id="O17" value="90.6" lower_limit="72.3" upper_limit="97.3"/>
                    <measurement group_id="O18" value="97.7" lower_limit="93.5" upper_limit="99.3"/>
                    <measurement group_id="O19" value="99.0" lower_limit="97.4" upper_limit="99.7"/>
                    <measurement group_id="O20" value="98.3" lower_limit="95.4" upper_limit="99.5"/>
                    <measurement group_id="O21" value="98.4" lower_limit="95.9" upper_limit="99.6"/>
                    <measurement group_id="O22" value="33.0" lower_limit="-27.1" upper_limit="67.3"/>
                    <measurement group_id="O23" value="93.8" lower_limit="87.0" upper_limit="97.3"/>
                    <measurement group_id="O24" value="95.8" lower_limit="90.2" upper_limit="98.3"/>
                    <measurement group_id="O25" value="97.0" lower_limit="92.5" upper_limit="98.9"/>
                    <measurement group_id="O26" value="99.8" lower_limit="99.5" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Concentration (Cmax) of Albendazole and Its Metabolites</title>
        <description>To determine maximum drug concentration (Cmax) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
        <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
        <posting_date>01/2022</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Reach Cmax (Tmax) of Albendazole and Its Metabolites</title>
        <description>To determine time to reach Cmax (tmax) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
        <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
        <posting_date>01/2022</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Curve (AUC) of Albendazole and Its Metabolites</title>
        <description>To determine the area under the curve (AUC) of albendazole and its metabolites in adults (≥ 21 years), preschool-aged (2-5 years) and school-aged children (6-12 years). Albendazole and its metabolites (albendazole sulfoxide and albendazole sulfone) will be quantified using a validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method. Drug concentrations will be calculated by interpolation from a calibration curve with a foreseen limit of quantification of approximately 1-5 ng/ml.</description>
        <time_frame>0, 1, 2, 3, 4, 6, 8, 24 hours post-dosing</time_frame>
        <posting_date>01/2022</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected at 3 hours and 24 hours after treatment.</time_frame>
      <desc>After a lengthy period of recruitment, it was decided to eliminate the placebo group for the PSAC cohort against hookworm.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo Against T. Trichiura in PSAC</title>
          <description>Placebo against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="E2">
          <title>ALB 200 mg Against T. Trichiura in PSAC</title>
          <description>200 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="E3">
          <title>ALB 400 mg Against T. Trichiura in PSAC</title>
          <description>400 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="E4">
          <title>ALB 600 mg Against T. Trichiura in PSAC</title>
          <description>600 mg of albendazole against T. trichiura in preschool-aged children</description>
        </group>
        <group group_id="E5">
          <title>Placebo Against T. Trichiura in SAC</title>
          <description>Placebo against T. trichiura in school-aged children</description>
        </group>
        <group group_id="E6">
          <title>ALB 400 mg Against T. Trichiura in SAC</title>
          <description>400 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="E7">
          <title>ALB 600 mg Against T. Trichiura in SAC</title>
          <description>600 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="E8">
          <title>ALB 800 mg Against T. Trichiura in SAC</title>
          <description>800 mg of albendazole against T. trichiura in school-aged children</description>
        </group>
        <group group_id="E9">
          <title>Placebo Against T. Trichiura in Adults</title>
          <description>Placebo against T. trichiura in adults</description>
        </group>
        <group group_id="E10">
          <title>ALB 400 mg Against T. Trichiura in Adults</title>
          <description>400 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="E11">
          <title>ALB 600 mg Against T. Trichiura in Adults</title>
          <description>600 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="E12">
          <title>ALB 800 mg Against T. Trichiura in Adults</title>
          <description>800 mg of albendazole against T. trichiura in adults</description>
        </group>
        <group group_id="E13">
          <title>Placebo Against Hookworm in PSAC</title>
          <description>Placebo against hookworm in preschool-aged children</description>
        </group>
        <group group_id="E14">
          <title>ALB 200 mg Against Hookworm in PSAC</title>
          <description>200 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="E15">
          <title>ALB 400 mg Against Hookworm in PSAC</title>
          <description>400 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="E16">
          <title>ALB 600 mg Against Hookworm in PSAC</title>
          <description>600 mg of albendazole against hookworm in preschool-aged children</description>
        </group>
        <group group_id="E17">
          <title>Placebo Against Hookworm in SAC</title>
          <description>Placebo against hookworm in school-aged children</description>
        </group>
        <group group_id="E18">
          <title>ALB 200 mg Against Hookworm in SAC</title>
          <description>200 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="E19">
          <title>ALB 400 mg Against Hookworm in SAC</title>
          <description>400 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="E20">
          <title>ALB 600 mg Against Hookworm in SAC</title>
          <description>600 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="E21">
          <title>ALB 800 mg Against Hookworm in SAC</title>
          <description>800 mg of albendazole against hookworm in school-aged children</description>
        </group>
        <group group_id="E22">
          <title>Placebo Against Hookworm in Adults</title>
          <description>Placebo against hookworm in adults</description>
        </group>
        <group group_id="E23">
          <title>ALB 200 mg Against Hookworm in Adults</title>
          <description>200 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="E24">
          <title>ALB 400 mg Against Hookworm in Adults</title>
          <description>400 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="E25">
          <title>ALB 600 mg Against Hookworm in Adults</title>
          <description>600 mg of albendazole against hookworm in adults</description>
        </group>
        <group group_id="E26">
          <title>ALB 800 mg Against Hookworm in Adults</title>
          <description>800 mg of albendazole against hookworm in adults</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Inpatient hospitalization due to clinical malaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" events="0" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" events="0" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="4" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="3" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="37"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="4" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E13" subjects_at_risk="0"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E26" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jennifer Keiser, PhD</name_or_title>
      <organization>Swiss Tropical and Public Health Institute</organization>
      <phone>+41 (61) 284 8218</phone>
      <email>jennifer.keiser@swisstph.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

